US Archives - Page 7 of 79 - European Medical Journal

JAK Inhibitors for Atopic Dermatitis: AAD 2025

ATOPIC dermatitis (AD) is one of the most common chronic inflammatory skin diseases in the world, affecting 15–25% of children and 3–7% of…

Derterminants of Therapeutic Resistance in Pediatric Atopic Dermatitis

Atopic dermatitis (AD) is a chronic skin condition affecting children, often influenced by various environmental and behavioral factors…

Updates on Melanoma and Melanocytic Neoplasms

The American Academy of Dermatology (AAD) Annual Meeting is where many of the largest breakthroughs within the field of dermatology are…

Scarring Alopecias in a Pediatric Trichology Clinic

Scarring alopecias (SA) are uncommon, and despite their morbidity, research on pediatric patients remains limited. Data on the most…

The Intersection of Climate Change, Air Pollution, and Dermatology: AAD 2025

The impact of air pollution and our changing climate on dermatologic disease is a new and emerging area of research. The American…

Concerns with Cosmetic Procedures in Skin of Color

In the United States, patients with skin of color (SOC) face significant healthcare disparities. Recognizing and addressing the…

Ethics of Treating Actinic Keratosis in Patients of Advanced Age

This ethics discussion highlights the complexities of treating actinic keratoses (AK) in elderly patients, particularly those in their…

Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy?

Acral digital ischemia associated with immune checkpoint inhibitor (ICI) use is a rare and poorly understood toxicity. The authors report…

Why Patients With Rheumatoid Arthritis Are Losing Sleep

New research reveals that adults with rheumatoid arthritis (RA) are significantly more likely to develop sleep disorders, including insomnia, than those without the disease, a finding that raises important questions for rheumatologists and primary care providers.

Why Working-Age Adults Need a Stronger Flu Shot

Each flu season, influenza quietly inflicts a heavy toll on U.S. adults aged 18 to 64, with hospitalizations and deaths mounting, especially among older adults and those with chronic conditions.